MedPath

PARTNER II: Improving Patient and Family Centered Care in Advanced Critical Illness

Not Applicable
Completed
Conditions
Anxiety
Depression
Interventions
Behavioral: PARTNER II
Registration Number
NCT02445937
Lead Sponsor
University of Pittsburgh
Brief Summary

This is a stepped wedged randomized controlled trial comparing the PARTNER intervention with usual care in 5 Intensive Care Units. The overarching goal of this research project to ensure patient-centered decisions about the use of intensive treatments for patients with advanced critical illness. In a prior project, the investigators developed the PARTNER program (PAiring Re-engineered ICU Teams with Nurse-driven Education and OutReach), a 4-facet, team-based intervention that re-engineers how surrogates are supported in ICUs, including: 1) changing care "defaults" to ensure clinician-family meetings within 48 hours of enrollment and frequently thereafter; 2) protocolized, nurse-administered coaching and emotional support of surrogates before and during clinician-family meetings, 3) increased use of palliative care services for patients with a poor prognosis. The investigators propose to begin deployment of the PARTNER II program in the spring of 2015 enrolling 690 surrogate decision makers in 5 ICUs using a stepped wedge design. The investigators expect to achieve the following project goals:

1. To increase the patient-centeredness of end-of-life decisions, and to increase the quality of clinician-family communication.

2. To decrease the psychological burden on family members acting as surrogates.

3. To reduce total health care costs by decreasing the duration of use of burdensome, invasive treatments at the end of life.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
848
Inclusion Criteria
  • 18 years of age or older
  • Surrogate decision maker for ICU patient in one of 5 UPMC ICU's
Read More
Exclusion Criteria
  • Non-English Speaking
  • Surrogate's loved one is for organ transplantation
  • Not physically able to participate in family meeting
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
Behavioral: The PARTNER II InterventionPARTNER IIThe PARTNER intervention is a multifaceted intervention delivered by a trained "PARTNER Champion" who has undergone 16 hours of intense communication training, with audit and feedback, quarterly booster training, and expert implementation support. Additionally, there is academic detailing of ICU physicians and ICU bedside nurses to augment the intervention. The PARTNER Intervention deploys three strategies to improve: 1) the timeliness and frequency of clinician-family communication, 2) the emotional and decision support provided to families and 3) the appropriate involvement of palliative care specialists.
Primary Outcome Measures
NameTimeMethod
Quality of Communication (QOC) scaleAt 6 months

We will assess quality of communication in family members in a telephone interview 6 months after enrollment using the validated13 item Quality of Communication Scale.

Secondary Outcome Measures
NameTimeMethod
Hospital Anxiety and Depression ScaleAt 6 months

We will assess symptom burden of anxiety and depression in family members in a telephone interview 6 months after enrollment using the validated 14-item Hospital Anxiety and Depression scale (HADS).

Patient-Centeredness of Care ScaleAt 6 months

We will assess Patient Centeredness of Care, using the 12-item Patient-Perceived Patient-Centeredness of Care Scale (PPPC) adapted for use by surrogates.

Intensive Care Unit Length of StayParticipants will be followed for duration of ICU stay, an expected average of 21 days

We will assess the Intensive Care Unit length of stay as assessed by abstraction of this information from the medical record.

Impact of Events ScaleAt 6 months

We will assess symptoms of post-traumatic stress in family members in a telephone interview 6 months after enrollment using the validated 22 item Impact of Events Scale.

Decision Regret ScaleAt 6 months

We will assess Decisional Regret by family members in a telephone interview 6 months after enrollment using the validated 5 item Decision Regret Scale across treatment groups.

Trial Locations

Locations (2)

UPMC Hamot

🇺🇸

Erie, Pennsylvania, United States

UPMC Presby/Shady

🇺🇸

Pittsburgh, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath